Changeflow GovPing Pharma & Drug Safety EPO Patent Application: Controlled Poration Met...
Routine Notice Added Final

EPO Patent Application: Controlled Poration Methods

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030613A1 concerning systems, devices, and methods for controlled poration and substance delivery into the cellular nucleus. The application was published on March 18, 2026, and lists various IPC classifications related to biotechnology and cell manipulation.

What changed

The European Patent Office (EPO) has published a patent application, EP2026030613A1, detailing "Controlled Poration Methods" for substance delivery into the cellular nucleus. The publication date is March 18, 2026, and it includes several International Patent Classification (IPC) codes such as C12M and C12N, indicating its relevance to biotechnology and laboratory equipment for biological research.

This publication represents a new patent application and does not impose immediate regulatory obligations on companies. However, it signifies potential future developments in biotechnology and drug delivery systems. Companies operating in the pharmaceutical and biotechnology sectors should be aware of this filing as it may relate to their intellectual property landscape and future research directions. No specific compliance actions or deadlines are associated with this patent publication.

Source document (simplified)

← EPO Patent Bulletin

SYSTEMS, DEVICES, AND METHODS FOR CONTROLLED PORATION OF AND SUBSTANCE DELIVERY INTO THE CELLULAR NUCLEUS

Publication EP2026030613A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12M 1/26 20060101AFI20260208BHEP C12M 1/34 20060101ALI20260208BHEP C12M 1/42 20060101ALI20260208BHEP C12M 3/06 20060101ALI20260208BHEP C12N 15/89 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Controlled Poration Methods SYSTEMS, DEVICES, AND METHODS FOR CONTROLLED PORATION OF AND SUBSTANCE DELIVERY INTO THE CELLULAR NUCLEUS

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030613A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Delivery Systems Biotechnology Research
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Medical Devices

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.